Patent Assignment
Reel/Frame 033414/0595
Assignment of Assignor's Interest
Recorded: 2014-07-29
Pages: 9
Assignor
SEACHAID PHARMACEUTICALS, INC.
Executed: 2014-05-30
Assignee
K2 THERAPEUTICS, INC.
WALTHAM WOODS CORPORATE CENTER, 890 WINTER STREET, SUITE 140, WALTHAM, MASSACHUSETTS, 02451
Covered Properties
(4)
Antifungal Agents and Uses Thereof
PCT:
PCT/US2012/027451 ↗
Dosing Regimens for Echinocandin Class Compounds
PCT:
PCT/US2013/031678 ↗
Antifungal Agents and Uses Thereof
Antifungal Agents and Uses Thereof
Related Assignments
(10)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 19, 2012
From: RADHAKRISHNAN, BALASINGHAM
To: SEACHAID PHARMACEUTICALS, INC.
Reel/Frame 027885/0212 →
Assignment of Assignor's Interest
Apr 2, 2014
From: JAMES, KENNETH DUKE, JR.; LAUDEMAN, CHRISTOPHER PATRICK
To: SEACHAID PHARMACEUTICALS, INC.
Reel/Frame 032583/0788 →
Assignment of Assignor's Interest
Jul 28, 2014
From: JAMES, KENNETH DUKE, JR.; LAUDEMAN, CHRISTOPHER PATRICK; MALKAR, NAVDEEP BALKRISHNA
To: SEACHAID PHARMACEUTICALS, INC.
Reel/Frame 033401/0894 →
Assignment of Assignor's Interest
Jul 28, 2014
From: RADHAKRISHNAN, BALASINGHAM
To: SEACHAID PHARMACEUTICALS, INC.
Reel/Frame 033402/0076 →
Change of Name
Aug 13, 2014
From: K2 THERAPEUTICS, INC.
To: CIDARA THERAPEUTICS, INC.
Reel/Frame 033532/0301 →
Assignment of Assignor's Interest
Sep 10, 2014
From: JAMES, KENNETH DUKE, JR.; LAUDEMAN, CHRISTOPHER PATRICK; MALKAR, NAVDEEP BALKRISHNA
To: SEACHAID PHARMACEUTICALS, INC.
Reel/Frame 033707/0397 →
Change of Name
Oct 20, 2014
From: K2 THERAPEUTICS, INC.
To: CIDARA THERAPEUTICS, INC.
Reel/Frame 034017/0543 →
Assignment of Assignor's Interest
Jan 30, 2015
From: RADHAKRISHNAN, BALASINGAM; JAMES, KENNETH DUKE, JR.; VAIDYA, ANURADHA; POLOWY, KAREN
To: SEACHAID PHARMACEUTICALS, INC.
Reel/Frame 034854/0480 →
Assignment of Assignor's Interest
Oct 11, 2024
From: CIDARA THERAPEUTICS, INC.
To: NAPP PHARMACEUTICAL GROUP LIMITED
Reel/Frame 069163/0195 →
Assignment of Assignor's Interest
Oct 22, 2024
From: CIDARA THERAPEUTICS, INC.
To: NAPP PHARMACEUTICAL GROUP LIMITED
Reel/Frame 069208/0471 →